β¨ Medicines Approval Notices
29 APRIL 2010 NEW ZEALAND GAZETTE, No. 48 1335
Product: Astromide
Active Ingredient: Temozolomide 100mg
Dosage Form: Capsule
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Orion Pharma, Turku, Finland
Product: Astromide
Active Ingredient: Temozolomide 140mg
Dosage Form: Capsule
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Orion Pharma, Turku, Finland
Product: Astromide
Active Ingredient: Temozolomide 180mg
Dosage Form: Capsule
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Orion Pharma, Turku, Finland
Product: Astromide
Active Ingredient: Temozolomide 250mg
Dosage Form: Capsule
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturer: Orion Pharma, Turku, Finland
Product: Gemcitabine
Active Ingredient: Gemcitabine hydrochloride 227.7mg equivalent to 200mg gemcitabine
Dosage Form: Powder for injection
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India
Product: Gemcitabine
Active Ingredient: Gemcitabine hydrochloride 1138.5mg equivalent to 1000mg gemcitabine
Dosage Form: Powder for injection
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Intas Pharmaceuticals Limited, Ahmedabad, India
Product: Jurnista
Active Ingredient: Hydromorphone hydrochloride 8mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, United States of America
Product: Jurnista
Active Ingredient: Hydromorphone hydrochloride 16mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, United States of America
Product: Jurnista
Active Ingredient: Hydromorphone hydrochloride 32mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, United States of America
Product: Jurnista
Active Ingredient: Hydromorphone hydrochloride 64mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, United States of America
Product: Panadol Caplet
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturers: GlaxoSmithKline Dungarvan Limited, Waterford, Ireland
GlaxoSmithKline Australia Pty Limited, Ermington, Australia
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare22 April 2010
Medicines, Approval, Distribution, Pharmaceuticals
NZ Gazette 2010, No 48